Japanese encephalitis (JE) is preventable using the affordable, effective, and safe live attenuated SA 14-14-2 JE vaccine (CD-JEV). We used a Markov model to evaluate the cost-effectiveness of 1 dose of CD-JEV compared with no vaccination in 3 ...
An Nguyen +10 more
doaj +1 more source
Comparing the immunogenicity and safety of 3 Japanese encephalitis vaccines in Asia-Pacific area: A systematic review and meta-analysis [PDF]
Shiyuan Wang +5 more
openalex +1 more source
Ablation of regulatory T cells lead to compromised quality of humoral immunity to SA14-14-2 live attenuated Japanese encephalitis vaccine [PDF]
Bhushan Nikam +3 more
openalex +1 more source
Japanese encephalitis vaccine in travelers
Extensive vaccination against Japanese encephalitis (JE) has been carried out in many Asian countries for the past 20 years and is also increasingly recommended for travelers to endemic areas. Concerns have been raised regarding potential neurological and allergic side effects of the currently available JE vaccine, which is manufactured from mouse ...
openaire +2 more sources
Screening of Protective Antigens of Japanese Encephalitis Virus by DNA Immunization: a Comparative Study with Conventional Viral Vaccines [PDF]
Hsin–Wei Chen +7 more
openalex +1 more source
Studies on Japanese B Encephalitis Virus Vaccines from Tissue Culture [PDF]
Medhat A. Darwish, William McD. Hammon
openalex +1 more source
The alarming spread of Japanese encephalitis: A growing public health concern
Japanese encephalitis (JE) is a zoonotic infectious disease transmitted by mosquitoes. JE is caused by the Japanese encephalitis virus (JEV), a member of the flavivirus genus.
Anindita Riesti Retno Arimurti +17 more
doaj +1 more source
Prevention, diagnosis, and management of Japanese encephalitis in children
Rashmi Kumar Department of Pediatrics, King George Medical University, Lucknow (UP), India Abstract: Japanese encephalitis is the single largest cause of viral encephalitis in the world today.
Kumar R
doaj
Viral vector- and virus-like particle-based vaccines against infectious diseases: A minireview
To overcome the limitations of conventional vaccines, new platforms for vaccine design have emerged such as those based on viral vectors and virus-like particles (VLPs).
Ruth Henríquez, Isabel Muñoz-Barroso
doaj +1 more source

